Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HCA | Common Stock | Gift | $0 | -450 | -1.78% | $0.00 | 24.8K | Oct 31, 2022 | Direct | F1 |
transaction | HCA | Common Stock | Sale | -$1.03M | -4K | -16.11% | $257.11 | 20.8K | Feb 1, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HCA | Stock Appreciation Right | Award | $0 | +14.5K | $0.00 | 14.5K | Jan 30, 2023 | Common Stock | 14.5K | $253.30 | Direct | F3 |
Id | Content |
---|---|
F1 | Includes 2,330.5543 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.1031 to $257.285, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. |